Howard Horn

2019

In 2019, Howard Horn earned a total compensation of $2.2M as Chief Financial Officer at Vir Biotechnology.

Compensation breakdown

Non-Equity Incentive Plan$174,720
Option Awards$1,614,687
Salary$413,333
Other$11,200
Total$2,213,940

Horn received $1.6M in option awards, accounting for 73% of the total pay in 2019.

Horn also received $174.7K in non-equity incentive plan, $413.3K in salary and $11.2K in other compensation.

Rankings

In 2019, Howard Horn's compensation ranked 5,409th out of 13,971 executives tracked by ExecPay. In other words, Horn earned more than 61.3% of executives.

ClassificationRankingPercentile
All
5,409
out of 13,971
61st
Division
Manufacturing
2,020
out of 5,701
65th
Major group
Chemicals And Allied Products
718
out of 2,200
67th
Industry group
Drugs
602
out of 1,886
68th
Industry
Biological Products, Except Diagnostic Substances
140
out of 389
64th
Source: SEC filing on April 6, 2020.

Horn's colleagues

We found two more compensation records of executives who worked with Howard Horn at Vir Biotechnology in 2019.

2019

George Scangos

Vir Biotechnology

Chief Executive Officer

2019

Herbert Virgin

Vir Biotechnology

Chief Scientific Officer

News

In-depth

You may also like